IMCR

Immunocore Holdings plc - ADR

31.17

USD

-1.25

-3.86%

Sep 23, 12:43 UTC -4

Open

Immunocore Holdings plc - ADR Profile

About

Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.

Info & Links

CEO

Bahija Jallal

Headquarters

92 PARK DRIVE, MILTON PARK, ABINGDON
OXFORDSHIRE, X0 OX14 4RY, UNITED KINGDOM

Auditor

Deloitte LLP

Share holders

Employees

524

Immunocore Holdings plc - ADR Statistics

Valuation Measures

Market Capitalization²

1.61B

Enterprise Value

1.51B

Enterprise Value/EBITDA(ttm)

-79.82

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.85

Price to Book(mrq)

3.95

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

98.89%

Operating Margin(ttm)

-4.20%

Profit Margin(ttm)

-4.37%

Return on Equity(ttm)

-4.54%

Return on Invested Capital(ttm)

-2.36%

Return on Assets(ttm)

-1.66%

Income Statement

Revenue(ttm)

430.77M

Revenue Per Share(ttm)

8.36

Gross Profit(ttm)

426.04M

EBITDA(ttm)³

-18.97M

Net Income Available to Common(ttm)

-18.07M

Diluted EPS(ttm)

-0.37

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

-6.26%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

51.50M

Dividend Yield

0.00%

Float⁴

46.30M

% Held by Insiders

10.10%

% Held by Institutions

84.50%

Balance Sheet

Total Cash(mrq)

880.21M

Total Cash Per Share(mrq)

17.09

Total Debt(mrq)

394.21M

Total Debt/Equity(mrq)

93.90%

Current Ratio(mrq)

4.47%

Quick Ratio(mrq)

4.44%

Book Value Per Share(mrq)

8.15

Cash Flow

Operating Cash Flow Per Share(ytd)

0.04

Free Cash Flow(ytd)

-414.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.